297 related articles for article (PubMed ID: 24567933)
1. Association of Chromosomal Translocation and MiRNA Expression with The Pathogenesis of Multiple Myeloma.
Saki N; Abroun S; Hajizamani S; Rahim F; Shahjahani M
Cell J; 2014; 16(2):99-110. PubMed ID: 24567933
[TBL] [Abstract][Full Text] [Related]
2. miRNA and cancer; computational and experimental approaches.
Tutar Y
Curr Pharm Biotechnol; 2014; 15(5):429. PubMed ID: 25189575
[TBL] [Abstract][Full Text] [Related]
3. Expression of Peripheral Blood miRNA-720 and miRNA-1246 Can Be Used as a Predictor for Outcome in Multiple Myeloma Patients.
Ren Y; Li X; Wang W; He W; Wang J; Wang Y
Clin Lymphoma Myeloma Leuk; 2017 Jul; 17(7):415-423. PubMed ID: 28601493
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA in Multiple Myeloma - A Role in Pathogenesis and Prognostic Significance.
Puła A; Robak P; Robak T
Curr Med Chem; 2021 Oct; 28(33):6753-6772. PubMed ID: 33949926
[TBL] [Abstract][Full Text] [Related]
5. Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis.
Alsaadi M; Khan MY; Dalhat MH; Bahashwan S; Khan MU; Albar A; Almehdar H; Qadri I
Diagnostics (Basel); 2021 Sep; 11(10):. PubMed ID: 34679437
[TBL] [Abstract][Full Text] [Related]
6. Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets.
Wang D; Qiu C; Zhang H; Wang J; Cui Q; Yin Y
PLoS One; 2010 Sep; 5(9):. PubMed ID: 20927335
[TBL] [Abstract][Full Text] [Related]
7. microRNAs as oncogenes and tumor suppressors.
Zhang B; Pan X; Cobb GP; Anderson TA
Dev Biol; 2007 Feb; 302(1):1-12. PubMed ID: 16989803
[TBL] [Abstract][Full Text] [Related]
8. MiRNA as a Potential Target for Multiple Myeloma Therapy-Current Knowledge and Perspectives.
Szudy-Szczyrek A; Ahern S; Krawczyk J; Szczyrek M; Hus M
J Pers Med; 2022 Aug; 12(9):. PubMed ID: 36143213
[TBL] [Abstract][Full Text] [Related]
9. MicroRNAs: non coding pleiotropic factors in development, cancer prevention and treatment.
Fazi F; Blandino G
Microrna; 2013; 2(2):81. PubMed ID: 25070777
[TBL] [Abstract][Full Text] [Related]
10. miRNAs in multiple myeloma--a survival relevant complex regulator of gene expression.
Seckinger A; Meißner T; Moreaux J; Benes V; Hillengass J; Castoldi M; Zimmermann J; Ho AD; Jauch A; Goldschmidt H; Klein B; Hose D
Oncotarget; 2015 Nov; 6(36):39165-83. PubMed ID: 26472281
[TBL] [Abstract][Full Text] [Related]
11. MicroRNAs and lung cancer: new oncogenes and tumor suppressors, new prognostic factors and potential therapeutic targets.
Ortholan C; Puissegur MP; Ilie M; Barbry P; Mari B; Hofman P
Curr Med Chem; 2009; 16(9):1047-61. PubMed ID: 19275611
[TBL] [Abstract][Full Text] [Related]
12. Altered Expression of MicroRNAs in the Bone Marrow of Multiple Myeloma Patients and their Relationship to Cytogenetic Aberrations.
Attia HRM; Abdelrahman AH; Ibrahim MH; Eid MM; Eid OM; Sallam MT; El Gammal MM; Kamel MM
Curr Pharm Biotechnol; 2020; 21(13):1394-1401. PubMed ID: 32196445
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs in Breast Cancer: Diagnostic and Therapeutic Potential.
Asiaf A; Ahmad ST; Arjumand W; Zargar MA
Methods Mol Biol; 2018; 1699():23-43. PubMed ID: 29086366
[TBL] [Abstract][Full Text] [Related]
14. miRNAs in Melanoma: Tumor Suppressors and Oncogenes with Prognostic Potential.
Wozniak M; Mielczarek A; Czyz M
Curr Med Chem; 2016; 23(28):3136-3153. PubMed ID: 27666934
[TBL] [Abstract][Full Text] [Related]
15. Dysregulation of miRNA in Leukemia: Exploiting miRNA Expression Profiles as Biomarkers.
Anelli L; Zagaria A; Specchia G; Musto P; Albano F
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281210
[TBL] [Abstract][Full Text] [Related]
16. MicroRNAs in Cancer.
Garzon R; Calin GA; Croce CM
Annu Rev Med; 2009; 60():167-79. PubMed ID: 19630570
[TBL] [Abstract][Full Text] [Related]
17. The role of circulating miRNAs in multiple myeloma.
Zhang J; Xiao X; Liu J
Sci China Life Sci; 2015 Dec; 58(12):1262-9. PubMed ID: 26607481
[TBL] [Abstract][Full Text] [Related]
18. The Role and Function of microRNA in the Pathogenesis of Multiple Myeloma.
Handa H; Murakami Y; Ishihara R; Kimura-Masuda K; Masuda Y
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31698726
[TBL] [Abstract][Full Text] [Related]
19. Circulating microRNAs: new biomarkers in diagnosis, prognosis and treatment of cancer (review).
Allegra A; Alonci A; Campo S; Penna G; Petrungaro A; Gerace D; Musolino C
Int J Oncol; 2012 Dec; 41(6):1897-912. PubMed ID: 23026890
[TBL] [Abstract][Full Text] [Related]
20. Cancer-related microRNAs and their role as tumor suppressors and oncogenes in hepatocellular carcinoma.
Gailhouste L; Ochiya T
Histol Histopathol; 2013 Apr; 28(4):437-51. PubMed ID: 23224781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
